| Jan-erin Miller, | |
|
644 N Chase St Ste 104, Athens, GA 30601-1960 | |
| (855) 284-7483 | |
| (617) 807-0958 |
| Full Name | Jan-erin Miller |
|---|---|
| Gender | Female |
| Speciality | Psychologist - Clinical |
| Location | 644 N Chase St Ste 104, Athens, Georgia |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235909748 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103TC0700X | Psychologist - Clinical | PSY004738 (Georgia) | Primary |
| Entity Name | Thrive Counseling Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1215181300 PECOS PAC ID: 0749458420 Enrollment ID: O20120504000149 |
News Archive
Cyclacel Pharmaceuticals, Inc., a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious disorders, today announced that it received a complaint filed by Celgene Corporation seeking a declaration from the court that four Cyclacel-owned patents, which claim the use of romidepsin injection in T-cell lymphomas, are not infringed by Celgene's products and are invalid.
Head and neck cancer outcomes associated with race may be more closely linked to social and behavioral factors than biological differences, especially for African Americans, according to a new Henry Ford Hospital study.
Sepsis kills more people than breast, colorectal, pancreatic, and prostate cancers combined. Outside of coronary care units, it is the leading cause of mortality in intensive care units. Every year 18 million people worldwide develop this potentially fatal disease. Thanks to a generous grant of $138,238.65 from the Jesse and Julie Rasch Foundation, Lawson Health Research Institute's Dr. Michael Sharpe is exploring a new sepsis therapy using Vitamin C.
DNAnexus, Inc. today announced the commercial launch of its web-based service for analyzing, visualizing, and managing next-generation DNA sequencing data. Andreas Sundquist, Ph.D., co-founder and CEO, will introduce the solution publicly for the first time today at the annual Bio-IT World Conference and Expo in Boston, Massachusetts.
Researchers from Mount Sinai School of Medicine have found a new mechanism that explains how certain immune cells are activated to create protective antibodies against infections or pathological antibodies such as those present in autoimmune diseases like lupus and rheumatoid arthritis. The research is published online in the September issue of Nature Immunology.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jan-erin Miller, Po Box 748465, Atlanta, GA 30374-8465 Ph: (855) 284-7483 | Jan-erin Miller, 644 N Chase St Ste 104, Athens, GA 30601-1960 Ph: (855) 284-7483 |
News Archive
Cyclacel Pharmaceuticals, Inc., a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious disorders, today announced that it received a complaint filed by Celgene Corporation seeking a declaration from the court that four Cyclacel-owned patents, which claim the use of romidepsin injection in T-cell lymphomas, are not infringed by Celgene's products and are invalid.
Head and neck cancer outcomes associated with race may be more closely linked to social and behavioral factors than biological differences, especially for African Americans, according to a new Henry Ford Hospital study.
Sepsis kills more people than breast, colorectal, pancreatic, and prostate cancers combined. Outside of coronary care units, it is the leading cause of mortality in intensive care units. Every year 18 million people worldwide develop this potentially fatal disease. Thanks to a generous grant of $138,238.65 from the Jesse and Julie Rasch Foundation, Lawson Health Research Institute's Dr. Michael Sharpe is exploring a new sepsis therapy using Vitamin C.
DNAnexus, Inc. today announced the commercial launch of its web-based service for analyzing, visualizing, and managing next-generation DNA sequencing data. Andreas Sundquist, Ph.D., co-founder and CEO, will introduce the solution publicly for the first time today at the annual Bio-IT World Conference and Expo in Boston, Massachusetts.
Researchers from Mount Sinai School of Medicine have found a new mechanism that explains how certain immune cells are activated to create protective antibodies against infections or pathological antibodies such as those present in autoimmune diseases like lupus and rheumatoid arthritis. The research is published online in the September issue of Nature Immunology.
› Verified 9 days ago
Dr. Sylvia F. Knight, PH.D. Psychologist Medicare: Accepting Medicare Assignments Practice Location: 520 Kings Rd, Athens, GA 30606 Phone: 706-546-0257 Fax: 706-548-5609 | |
Dr. Anne W. Reynolds, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1751 S Lumpkin St, Athens, GA 30606 Phone: 706-546-5799 Fax: 706-354-8904 | |
Ann Weitzman-swain, PH.D. Psychologist Medicare: Accepting Medicare Assignments Practice Location: 1 Huntington Rd, Suite 801, Athens, GA 30606 Phone: 706-552-0450 Fax: 706-552-0450 | |
David Campbell, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 55 Carlton St, Athens, GA 30602 Phone: 706-542-8621 Fax: 706-583-0217 | |
Dr. Sandrine M Bosshardt, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 55 Carlton St, Athens, GA 30602 Phone: 865-804-0667 | |
Emily Mouilso, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: Uga Psychology Department, 125 Baldwin Street, Athens, GA 30602 Phone: 706-542-3032 | |
Jaclyn Peters, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1090 Founders Blvd, Suite B, Athens, GA 30606 Phone: 706-548-8697 Fax: 706-548-8698 |